Seizert Capital Partners, LLC Incyte Corp Transaction History

Seizert Capital Partners, LLC

$2.14 Billion
Q4 2024

A detailed history of Seizert Capital Partners, LLC transactions in Incyte Corp stock. As of the latest transaction made, Seizert Capital Partners, LLC holds 47,567 shares of INCY stock, worth $3.24 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

47,567

Previous 94,342 49.58%

Holding current value

$3.24 Million

Previous $6.24 Million 47.32%

% of portfolio

0.15%

Previous 0.29%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 06, 2025	SELL	$65.08 - $83.38 $3.04 Million - $3.9 Million	-46,775 Reduced 49.58%	47,567 $3.29 Million
Q3 2024 Nov 06, 2024	BUY	$57.33 - $68.61 $598,410 - $716,151	10,438 Added 12.44%	94,342 $6.24 Million
Q2 2024 Aug 07, 2024	SELL	$51.18 - $63.75 $150,827 - $187,871	-2,947 Reduced 3.39%	83,904 $5.09 Million
Q1 2024 May 01, 2024	BUY	$56.55 - $66.59 $5,315 - $6,259	94 Added 0.11%	86,851 $4.95 Million
Q4 2023 Feb 07, 2024	SELL	$52.16 - $64.19 $753,033 - $926,711	-14,437 Reduced 14.27%	86,757 $5.45 Million
Q3 2023 Nov 06, 2023	BUY	$57.77 - $65.93 $363,488 - $414,831	6,292 Added 6.63%	101,194 $5.85 Million
Q2 2023 Jul 27, 2023	SELL	$60.95 - $75.51 $74,359 - $92,122	-1,220 Reduced 1.27%	94,902 $5.91 Million
Q1 2023 May 09, 2023	SELL	$70.23 - $86.01 $320,880 - $392,979	-4,569 Reduced 4.54%	96,122 $6.95 Million
Q4 2022 Jan 30, 2023	BUY	$67.18 - $84.11 $20,019 - $25,064	298 Added 0.3%	100,691 $8.09 Million
Q3 2022 Nov 02, 2022	SELL	$66.18 - $82.86 $1.52 Million - $1.9 Million	-22,908 Reduced 18.58%	100,393 $6.69 Million
Q2 2022 Aug 04, 2022	SELL	$66.18 - $83.18 $44,274 - $55,647	-669 Reduced 0.54%	123,301 $9.37 Million
Q1 2022 May 03, 2022	SELL	$66.02 - $79.71 $143,131 - $172,811	-2,168 Reduced 1.72%	123,970 $9.85 Million
Q4 2021 Feb 08, 2022	BUY	$63.34 - $74.11 $78,098 - $91,377	1,233 Added 0.99%	126,138 $9.26 Million
Q3 2021 Nov 03, 2021	BUY	$68.67 - $84.02 $1.37 Million - $1.68 Million	20,015 Added 19.08%	124,905 $8.59 Million
Q2 2021 Aug 05, 2021	SELL	$79.87 - $87.53 $492,877 - $540,147	-6,171 Reduced 5.56%	104,890 $8.82 Million
Q1 2021 May 05, 2021	BUY	$76.02 - $100.5 $8.44 Million - $11.2 Million	111,061 New	111,061 $9.03 Million

Others Institutions Holding INCY

# of Institutions

706

Shares Held

189M

Call Options Held

909K

Put Options Held

489K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15.1B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Seizert Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Seizert Capital Partners, LLC with notifications on news.

Account

Seizert Capital Partners, LLC Incyte Corp Transaction History